Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The influence of osteoprotegerin (OPG) treatment on callus formation, callus tissue structural strength, apparent material properties, and histology of tibia fractures in rats was investigated after 3 weeks and 8 weeks of healing. OPG was given intravenously (10 mg/kg twice weekly) during the entire observation period, and control animals with fractures received vehicle only. When compared with control fractures after 3 weeks of healing, OPG treatment reduced the number of osteoclasts in the callus tissue (93%, P < 0.001) and hampered resorption of genuine cortical bone in the fracture line; OPG treatment did not influence callus dimensions, callus bone mineral content (BMC), fracture structural strength, or callus tissue apparent material properties. When compared with control fractures after 8 weeks of healing; OPG treatment reduced the number of osteoclasts in callus tissue (92%, P < 0.001), augmented callus dimensions (anteriorposterior diameter: 12%, P = 0.034, mediolateral diameter: 13%, P = 0.013), and increased callus BMC (50%, P = 0.007); OPG treatment hampered deposition of new woven bone at the fracture line of the genuine cortical bone (new woven bone present in all vehicle animals, but only in 13% of the OPG-treated animals (P < 0.001)); OPG treatment did not influence structural strength of the fractures, but decreased apparent material properties of the callus tissue (ultimate stress: 51%, P < 0.001; elastic modulus: 42%, P = 0.033). The experiment demonstrates that OPG treatment does not influence the early callus expansion and fracture strength. However, during the subsequent period of remodelling, OPG treatment impairs the normal remodeling and consolidation processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At wk 8, fracture calluses from OPGtreated rats were about 20% larger and had 30% greater BMC compared with vehicle controls.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [363]
In the citing paper
“Consistent with this notion, the delayed callus remodeling associated with OPG treatment in rats resulted in larger calluses that were able to withstand the same amount of biomechanical force as did the calluses of untreated rats (363).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [363]
In the citing paper
“Histological assessment of fracture calluses at wk 3 and 8 showed greater than 90% reductions in osteoclast numbers in OPG-treated rats compared with time-matched vehicle controls.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [363]
In the citing paper
“At wk 3, there were no reported differences in callus dimensions, BMC, or biomechanical strength of the callus between OPGand vehicle-treated controls.”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [363]
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130 · cited 2×
“These studies include osteoporosis [4], erosive arthritis [6], humoral hypercalcemia of malignancy [7, 8], experimental bone metastasis [9], and wear debris–induced osteolysis [10, 11].”
BackgroundBone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962 · cited 1×
“The key factor in the development and activation of osteoclasts is the receptor activator of NFjB ligand (RANKL), which binds to its receptor (RANK) on osteoclast precursor cells and stimulates osteoclastogenesis and bone resorption [1–3].”
BackgroundKong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856 · cited 1×
“These studies include osteoporosis [4], erosive arthritis [6], humoral hypercalcemia of malignancy [7, 8], experimental bone metastasis [9], and wear debris–induced osteolysis [10, 11].”
BackgroundBasic orthopaedic biomechanics
Mow, V. C., & Hayes, W. C. (1991) · Medical Entomology and Zoology · Cited by 655
Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
Hofbauer, L. C., & Heufelder, A. E. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100226 · Cited by 586 · cited 1×
“The key factor in the development and activation of osteoclasts is the receptor activator of NFjB ligand (RANKL), which binds to its receptor (RANK) on osteoclast precursor cells and stimulates osteoclastogenesis and bone resorption [1–3].”
BackgroundKon, T., Cho, T.-J., Aizawa, T., Yamazaki, M., Nooh, N., Graves, D., Gerstenfeld, L. C., & Einhorn, T. A. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1004 · Cited by 552 · cited 1×
“It has been demonstrated that cellular expression of OPG and RANKL in murine callus tissue is tightly coupled during fracture healing and is involved in the regulation of both endochondral resorption and remodeling [13].”
BackgroundThe effect of a single dose of osteoprotegerin in postmenopausal women.
Bekker, P. J., Holloway, D., Nakanishi, A., Arrighi, M., Leese, P. T., & Dunstan, C. R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.348 · Cited by 484 · cited 1×
“Furthermore, a clinical investigation with OPG in postmenopausal women has demonstrated that bone turnover could be reduced by only one single injection ofOPG [12].”
BackgroundZhang, J., Dai, J., Qi, Y., Lin, D.-L., Smith, P., Strayhorn, C., Mizokami, A., Fu, Z., Westman, J., & Keller, E. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11685 · Cited by 452 · cited 1×
“These studies include osteoporosis [4], erosive arthritis [6], humoral hypercalcemia of malignancy [7, 8], experimental bone metastasis [9], and wear debris–induced osteolysis [10, 11].”
BackgroundAndreassen, T. T., Ejersted, C., & Oxlund, H. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.6.960 · Cited by 346 · cited 3×
“Fracture healing was examined in vivo using the rat tibia fracture model as we have described previously in detail [14, 15].”
BackgroundMethodSelf-citationMorony, S., Capparelli, C., Sarosi, I., Lacey, D. L., Dunstan, C. R., & Kostenuik, P. J. (2001) · PubMed · Cited by 318
Erben, R. G. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500215 · Cited by 317 · cited 1×
“After DXA measurements were obtained, the proximal part of the fractures was embedded in methyl methacrylate as described by Erben [17].”
MethodBasic Orthopaedic Biomechanics
&NA; (1991) · Journal of Clinical Engineering · doi:10.1097/00004669-199111000-00020 · Cited by 307
Cao, Y., Mori, S., Mashiba, T., Westmore, M. S., Ma, L., Sato, M., Akiyama, T., Shi, L., Komatsubara, S., Miyamoto, K., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.12.2237 · Cited by 248 · cited 2×
“Biphosphonates reduce the number of osteoclasts in callus tissue [27] and suppress remodeling of callus, thereby resulting in a higher content of woven bone [26, 29].”
BackgroundStructural Changes in the Forefoot of Individuals with Diabetes and a Prior Plantar Ulcer
Robertson, D. D., Mueller, M. J., Smith, K. E., Commean, P. K., Pilgram, T., & Johnson, J. E. (2002) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-200208000-00016 · Cited by 188
Effect of alendronate on fracture healing and bone remodeling in dogs
Peter, C. P., Cook, W. O., Nunamaker, D. M., Provost, M. T., Seedor, J. G., & Rodan, G. A. (1996) · Journal of Orthopaedic Research · doi:10.1002/jor.1100140113 · Cited by 185 · cited 1×
“However, other studies indicate no effects or even decreased callus strength by bisphosphonates [24, 25, 30, 31].”
BackgroundEffect of bisphosphonate (Incadronate) on fracture healing of long bones in rats.
Li, J., Mori, S., Kaji, Y., Mashiba, T., Kawanishi, J., & Norimatsu, H. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.6.969 · Cited by 178 · cited 2×
“Biphosphonates reduce the number of osteoclasts in callus tissue [27] and suppress remodeling of callus, thereby resulting in a higher content of woven bone [26, 29].”
BackgroundUlrich‐Vinther, M., Carmody, E. E., Goater, J. J., Søballé, K., O’Keefe, R. J., & Schwarz, E. M. (2002) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200208000-00017 · Cited by 157
Self-citationLi, C., Mori, S., Li, J., Kaji, Y., Akiyama, T., Kawanishi, J., & Norimatsu, H. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.429 · Cited by 155 · cited 4×
“Some investigators have found enhanced mechanical strength of the fractures in relation to bisphosphonate treatment [26, 28, 29].”
BackgroundInfluentialCapparelli, C., Kostenuik, P. J., Morony, S., Starnes, C. O., Weimann, B., Van, G. Y., Scully, S. A., Qi, M., Lacey, D. L., & Dunstan, C. R. (2000) · PubMed · Cited by 155
Kostenuik, P. J., Capparelli, C., Morony, S., Adamu, S., Shimamoto, G., Shen, V., Lacey, D. L., & Dunstan, C. R. (2001) · Endocrinology · doi:10.1210/endo.142.10.8437 · Cited by 140 · cited 1×
“We have administered 10 mg/kg of hOPG twice weekly, as previous experiments have demonstrated that this dose of hOPG ameliorated bone losses in rats after ovariectomy [32].”
MethodGrowth hormone stimulates bone formation and strength of cortical bone in aged rats
Andreassen, T. T., Jørgensen, P. H., Oxlund, H., Flyvbjerg, A., & Ørskov, H. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100710 · Cited by 140 · cited 1×
“Total volumes of both fractured and intact tibiae were gauged by using Archimedes principle [16], and the external callus volume was calculated as the volume of the fractured tibia minus the volume of the intact tibia [15].”
MethodSelf-citationAndreassen, T. T., Fledelius, C., Ejersted, C., & Oxlund, H. (2001) · Acta Orthopaedica Scandinavica · doi:10.1080/00016470152846673 · Cited by 129 · cited 2×
“Fracture healing was examined in vivo using the rat tibia fracture model as we have described previously in detail [14, 15].”
BackgroundMethodSelf-citationCapparelli, C., Morony, S., Warmington, K., Adamu, S., Lacey, D., Dunstan, C. R., Stouch, B., Martin, S., & Kostenuik, P. J. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.852 · Cited by 103 · cited 1×
“It has been shown that a single intravenous injection of hOPG (5 mg/kg) caused an approximately 95% reduction in osteoclast surface per bone surface after 10 days [33].”
BackgroundEfficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis
Goater, J. J., O'Keefe, R. J., Rosier, R. N., Puzas, J. E., & Schwarz, E. M. (2002) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(01)00083-3 · Cited by 103 · cited 1×
“These studies include osteoporosis [4], erosive arthritis [6], humoral hypercalcemia of malignancy [7, 8], experimental bone metastasis [9], and wear debris–induced osteolysis [10, 11].”
BackgroundLi, J., Mori, S., Kaji, Y., Kawanishi, J., Akiyama, T., & Norimatsu, H. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.10.2042 · Cited by 95 · cited 2×
“Biphosphonates reduce the number of osteoclasts in callus tissue [27] and suppress remodeling of callus, thereby resulting in a higher content of woven bone [26, 29].”
BackgroundResultEffect of EHDP on fracture healing in dogs
Lenehan, T. M., Balligand, M., Nunamaker, D. M., & Wood, F. E. (1985) · Journal of Orthopaedic Research · doi:10.1002/jor.1100030413 · Cited by 85 · cited 1×
“Although a variety of experimental models have been given bisphosphonates, the development of an augmented callus size is a common feature [21–30].”
BackgroundEffects of receptor activator of NFκB (RANK) signaling blockade on fracture healing.
Flick, L. M., Weaver, J. M., Ulrich‐Vinther, M., Abuzzahab, F., Zhang, X., Dougall, W. C., Anderson, D., O'Keefe, R. J., & Schwarz, E. M. (2003) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(03)00011-1 · Cited by 82 · cited 1×
“Treatment with repeated high doses of RANK:Fc resulted in increased murine callus formation and depletion of osteoclasts [20].”
BackgroundSelf-citationAndreassen, T. T., Willick, G. E., Morley, P., & Whitfield, J. F. (2004) · Calcified Tissue International · doi:10.1007/s00223-003-0093-6 · Cited by 72 · cited 1×
“The normal remodeling processes of healing fracture induce a substantial enhancement of the apparent material properties in the callus tissue [19].”
BackgroundSelf-citationNo adverse effects of clodronate on fracture healing in rats.
Madsen, J. E., Berg-larsen, T., Kirkeby, O. J., Falch, J. A., & Nordsletten, L. (1998) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679808997793 · Cited by 61 · cited 1×
“However, other studies indicate no effects or even decreased callus strength by bisphosphonates [24, 25, 30, 31].”
BackgroundLong-Term Administration of Clodronate Does Not Prevent Fracture Healing in Rats
Koivukangas, A., Tuukkanen, J., Kippo, K., J??ms??, T., Hannuniemi, R., Pasanen, I., V????n??nen, K., & Jalovaara, P. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200303000-00036 · Cited by 54 · cited 1×
“However, other studies indicate no effects or even decreased callus strength by bisphosphonates [24, 25, 30, 31].”
BackgroundClodronate increases the calcium content in fracture callus: An experimental study in rats
Nyman, M. T., Paavolainen, P., & Lindholm, T. S. (1993) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/bf00451880 · Cited by 44 · cited 1×
“Although a variety of experimental models have been given bisphosphonates, the development of an augmented callus size is a common feature [21–30].”
BackgroundEffect of clodronate on fracture healing in denervated rats
Tarvainen, R., Olkkonen, H., Nevalainen, T., Hyvönen, P. M., Arnala, I., & Alhava, E. M. (1994) · Bone · doi:10.1016/8756-3282(94)90320-4 · Cited by 40 · cited 1×
“However, other studies indicate no effects or even decreased callus strength by bisphosphonates [24, 25, 30, 31].”
BackgroundHealing of a tibial double osteotomy is modified by clodronate administration
Nyman, M. T., Gao, T., Lindholm, T. C., & Lindholm, T. S. (1996) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/bf00573453 · Cited by 30 · cited 1×
“Although a variety of experimental models have been given bisphosphonates, the development of an augmented callus size is a common feature [21–30].”
BackgroundBreakthrough in bone: the molecular mechanism of osteoclast/osteoblast coupling revealed
Schwarz, E. M., & O’Keefe, R. J. (2000) · Current Opinion in Orthopedics · doi:10.1097/00001433-200010000-00001 · Cited by 23 · cited 2×
“Hence, blocking RANKL s interaction with RANK in a dose-dependent manner, OPG is inhibiting osteoclast development and activation [2].”
Background曹, 永. (2004) · Medical Entomology and Zoology · Cited by 19
Shimizu‐Ishiura, M., Kawana, F., & Sasaki, T. (2002) · Journal of Electron Microscopy · doi:10.1093/jmicro/51.5.315 · Cited by 15 · cited 1×
“This interaction is negatively regulated by osteoprotegerin (OPG) [4, 5 ], which is a natural decoy binding protein that exclusively binds to RANKL.”
Background
Research works printed but not linked: 2
- S Morony, 2001, Cancer Res, 61, 4432
- C Capparelli, 2000, Cancer Res, 60, 783
Cited by
Bone remodeling during fracture repair: The cellular picture
Schindeler, A., McDonald, M. M., Bokko, P., & Little, D. G. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.004 · Cited by 961
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Cellular biology of fracture healing
Bahney, C. S., Zondervan, R. L., Allison, P., Theologis, A., Ashley, J. W., Ahn, J., Miclau, T., Marcucio, R. S., & Hankenson, K. D. (2019) · Journal of Orthopaedic Research · doi:10.1002/jor.24170 · Cited by 577
Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model
Alexander, K. A., Chang, M. K., Maylin, E. R., Kohler, T., Müller, R., Wu, A. C., Van Rooijen, N., Sweet, M. J., Hume, D. A., Raggatt, L. J., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.354 · Cited by 485
“Other studies in animal models of fracture have inhibited osteoclast number and function either via OPG,((52)) denosumab,((53)) or bisphosphonate treatment((53,54)) and concluded that osteoclasts were not required for normal callus formation but were important during hard callus remodeling.”
BackgroundKostenuik, P. J., Nguyen, H. Q., McCabe, J., Warmington, K. S., Kurahara, C., Sun, N., Chen, C., Li, L., Cattley, R. C., Van, G., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081112 · Cited by 443
“callus formation and positive effects on callus strength despite delays in callus remodeling.((46,47)) In summary, OPG and denosumab inhibit osteoclasto-”
Background
Metadata
- Authors
- Ulrich-Vinther, M., & Andreassen, T. T.
- Affiliations
- Aarhus University (DK)
- Venue
- Calcified Tissue International
- Published
- 2005-04
- Volume
- 76
- Issue
- 4
- Pages
- 280-286
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W2017820958
- Cited by
- 46
- References
- 36
- Citations by year
- 2025: 2 · 2024: 2 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 1 · 2015: 2 · 2014: 4 · 2013: 2 · 2012: 1
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- osteoprotegerin, fracture healing, callus, bone remodeling, osteoclasts, cortical bone resorption, fracture strength, elastic modulus, ultimate stress, bone mineral content, tibial fractures, RANKL inhibition
- MeSH terms
- Animals, Bony Callus, Female, Glycoproteins, Injections, Intravenous, Osteoclasts, Stress, Mechanical, Tibia, Absorptiometry, Photon, Bone Density, Weight-Bearing, Bone Remodeling, Fracture Healing, Rats, Wistar, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Compressive Strength, Rats, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.